Page 39 - MELLBY_MAGASIN_2025_ENG_SID

ANOCCA

“We employ a lot of extremely talented individuals, not just NO TIME FOR CELEBRATION – YET
scientists, but project managers and quality specialists, engineers, 2025 is the first year the Anocca team has not grown – it is now the
and software developers. The team has been decisive for our right size for executing both the scientific and clinical development
success”, says Reagan Jarvis and continues: on the short-term agenda. An intense, challenging and exciting time
with no time for milestone celebrations.
“The re-financing we received this year has been essential to take
the step into clinical trials“. “The celebrations start when we dose the first patient”, Reagan
Jarvis concludes. “Then we demonstrate that we can truly bring real
After receiving SEK 440 million in the last financing round, Anocca value to these patients with extremely high and eminent need."
was able to invest further in manufacturing technologies and infra-
structure to strengthen its position, as well in its own purposebuilt
software ecosystem for controlling the laboratory processes and
capturing and visualizing the complex data.

The re-financing we received this REAGAN JARVIS,
year has been essential to take the CEO

step into clinical trials

39